Lémur Innovation
Lémur Innovation is a French digital health SaaS company that builds connected software for pharmaceutical care in community pharmacies and hospitals, including medication reconciliation, patient accompaniment, prevention, and therapeutic education, all underpinned by its proprietary LemurIA AI layer and integrated with French healthcare card systems.
- Company typePrivate
- Founded2020
- HeadquartersPfulgriesheim, France
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Lémur Innovation does
Lémur Innovation is a privately held French digital health company (SAS, share capital €83,700) founded in 2019 in Pfulgriesheim, Alsace, that develops a connected suite of SaaS applications for pharmaceutical care delivery in community pharmacies and hospitals. The company addresses medication iatrogenicity — over 10,000 deaths and 130,000+ hospitalizations per year in France according to cited ENEIS 2009 and Urgemed 2018 studies — through structured workflows for medication reconciliation (BPM, CTM), patient accompaniment (APP Longs/Courts/Entretiens), prevention (BP), therapeutic education (ETP), self-administration (PAAM), and patient pathway management (PP), all underpinned by a proprietary AI layer called LemurIA that automates evaluation of reconciliation relevance and predicts iatrogenic risk.
The platform integrates with French national healthcare infrastructure (Carte CPS, Carte Vitale, INS) and is differentiated by an active city-hospital data link (ville-hôpital) reported effective in over 40% of pharmacies in certain territories. The company operates an annual subscription SaaS model with module-level pricing ranging from €5/month (APP Courts) to €350/month (CTM), complemented by one-time and annual communication packs (Pack Starter €35, Pack Com' €50/year), in-situ training services (Formations Lémur), and add-on licenses. Go-to-market combines direct online subscription via Stripe checkout, regional field sales through in-situ training and pharmacy salons (UPP 68-88, UPP Jura, UPP Montpellier, Positive Pharma evenings), and since January 2025 a national channel partnership with pharmaceutical distributor CERP, alongside a CPTS Pays des Couleurs (Isère) partnership signed April 2026 to deploy pharmaceutical missions at territorial scale. The team remains small (1–10 employees, TPE structure) with approximately 1,000 pharmacy subscribers referenced across the brand ecosystem.
Lémur Innovation firmographics
Firmographics- Name
- Lémur Innovation
- Legal name
- LEMUR INNOVATION
- Website
- https://lemur-innov.fr
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Lémur Innovation is a French digital health SaaS company that builds connected software for pharmaceutical care in community pharmacies and hospitals, including medication reconciliation, patient accompaniment, prevention, and therapeutic education, all underpinned by its proprietary LemurIA AI layer and integrated with French healthcare card systems.
- Ownership category
- akta.pro rank
Lémur Innovation industry classification
Industry- Product category
- Pharmacy Practice Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)
- akta.pro secondary industries
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)
Keywords
Where Lémur Innovation is headquartered
LocationHeadquarters
- HQ city
- Pfulgriesheim
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Lémur Innovation business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Software Subscription (SaaS): Annual subscription model for each software module (BPM, APP, BP, CTM, PP, ETP, PAAM). Subscriptions are billed annually with tacit renewal. Each module is priced independently. The subscription includes access to the web platform, software updates, and support.
- Communication Packs (One-time and Annual): Pack Starter is a one-time purchase at €35 HT for onboarding materials (posters, flyers, video, social media post, patient labels). Pack Com' is an annual subscription at €50 HT/year for semester-based promotional materials.
- Add-on Licenses and Accessories: Additional user profile AI licenses, patient labels (minimum 18 units), and touch tablet for patient interviews are sold as supplementary purchases to the core subscription.
- Professional Services - Training: In-situ training sessions and formation services provided to subscribers and non-subscribers, covering pharmaceutical care protocols, BPM, Bilans de Prévention, and product usage.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Lémur BPM - Medication Review Solution for Pharmacy |
| Subscription | Annual | Lémur APP Longs - Long-term Patient Pharmaceutical Accompaniment |
| Subscription | Annual | Lémur APP Courts - Short-term Patient Pharmaceutical Accompaniment |
| Subscription | Annual | Lémur APP Entretiens - Interview Module for TROD, Vaccination, Screening |
| Subscription | Annual | Lémur BP - Prevention Review by Age Group |
| Subscription | Annual | Lémur CTM - Medication Treatment Conciliation for Hospitals |
| Subscription | Annual | Lémur PP - Patient Pathways for Hospital |
| Subscription | Annual | Lémur ETP - Therapeutic Patient Education |
| Subscription | Annual | Lémur PAAM - Self-Administration of Medications |
| One time/ perpetual license | Annual | Pack Starter - Onboarding Communication Kit |
| Subscription | Annual | Pack Com' - Annual Communication Kit |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels9 records
Lémur Innovation product offering
Product offeringCore offering
Lémur Innovation develops and sells a SaaS suite of digital pharmaceutical care software for French community pharmacies, hospitals, clinics and rehabilitation centers. The offering centers on medication reviews (Bilan Partagé de Médication), patient accompaniment (Accompagnement Pharmaceutique des Patients), prevention assessments, hospital medication reconciliation (Conciliation des Traitements Médicamenteux), therapeutic patient education and self-administration tools — all powered by its proprietary LemurIA artificial intelligence for medication risk evaluation and city-hospital connectivity.
Product overview
Lémur Innovation offers a comprehensive suite of digital pharmaceutical care software organized into two main product lines: pharmacy (officine) products and hospital/clinic products. The core pharmacy portfolio includes Lémur BPM for Medication Review, Lémur APP Longs/APP Courts/APP Entretiens for differentiated levels of pharmaceutical patient accompaniment, and Lémur BP for Prevention Assessments — all integrated within a single platform and supported by add-on communication packs. The hospital portfolio centers on Lémur CTM for Medication Reconciliation (the flagship hospital solution), alongside Lémur PP for patient pathways, Lémur ETP for therapeutic patient education, and Lémur PAAM for medication self-administration management. All products are underpinned by LemurIA, the company's AI layer that automates analysis of medication reconciliation quality. The company operates on a SaaS subscription model with per-user licensing, and all solutions are deployed via a web platform accessible from browsers and tablets in French healthcare settings.
Differentiator
Problem solved
Functional benefit
Brands
- LemurIA: AI-powered tool integrated into Lémur Innovation's software solutions, including automated evaluation of medication reconciliation relevance and predictive capabilities for patient risk assessment.
- Lémur Télépathie
Products and services
- Lémur BPM (Bilan Partagé de Médication) Software solution for conducting Medication Reviews (Bilan Partagé de Médication) in community pharmacies, enabling pharmacists to perform structured medication reconciliation and patient follow-up with a target completion time of under 20 minutes. Targets French community pharmacists delivering the BPM mission under the pharmaceutical convention. EHPAD mode available.
- Lémur APP Longs Long-term pharmaceutical patient accompaniment module for chronic patients on anticoagulants, antiasthmatics or oral anticancer treatments, with customizable modules and time-saving features. Targets French community pharmacists managing chronic patient follow-up under the APP mission.
- Lémur APP Courts Short pharmaceutical accompaniment service for pregnant women and patients on Stage II analgesics, enabling brief structured consultations at the pharmacy counter. Includes prevention of dependency risk. Targets French community pharmacists delivering short APP interviews.
- Lémur APP Entretiens Module for conducting and tracking rapid diagnostic orientation tests (TROD) for strep throat (angine) and cystitis, vaccinations, and colorectal cancer screening kit delivery. Targets French community pharmacists expanding clinical services at the counter.
- Lémur BP (Bilan de Prévention) Prevention Assessment tool for age-based patient health risk identification, featuring patient data entry and facilitated patient recruitment for pharmacy-based preventive care consultations. Targets French community pharmacists delivering Bilans de Prévention across age brackets.
- Lémur CTM (Conciliation des Traitements Médicamenteux) Medication Treatment Reconciliation solution for hospitals and clinics, deploying in under 24 hours and supporting proactive and retroactive reconciliation workflows per HAS guidelines, with sector-based patient risk identification. Targets hospital pharmacists (PUI) and quality managers needing HAS certification compliance and care-transition safety.
- Lémur PP (Parcours Patients) Hospital patient pathway management solution based on the Arrêté du 28 février 2020, for day hospital and emergency short-stay unit (UHCD) patient care management. Targets hospital pharmacists and care pathway coordinators, with observed operational margin above 64% with implementation.
- Lémur ETP (Éducation Thérapeutique du Patient) Therapeutic Patient Education platform enabling structured consultations and accompaniment tools that reportedly increase patient observance by over 50%. Targets hospital teams and ambulatory programs running therapeutic education programs.
- Lémur PAAM (Patient Self-Administration of Medications) Patient Self-Administration of Medications module enabling hospital patients to self-administer their treatments, reportedly saving over 80% of nursing time on medication administration. Targets hospital teams seeking to reduce nursing workload while maintaining safety.
- Formations Lémur Training services including Lémur software training, DPC (Continuing Professional Development), pharmaceutical accompaniment training, pharmacy emergency care, geriatrics, TROD certification and Medication Review (BPM) training. Targets pharmacists, pharmacy teams and students needing accredited training and onboarding for Lémur software.
- Pack Starter One-time onboarding communication kit at €35 HT including 3 advertising posters for BPM promotion, 1 BPM flyer, 1 promotional video for pharmacy screens, 1 social media post, and 18 patient labels shipped at registration. Targets new community pharmacy subscribers deploying the BPM mission.
- Pack Com' Annual subscription communication kit at €50 HT/year including 1 new advertising poster per semester and 1 new promotional video per quarter for promotion of new pharmaceutical missions. Targets community pharmacies running ongoing patient communication campaigns.
Quantifiable outcome
- Average BPM completion time reduced to under 20 minutes
- +6 more outcomes
Companies that use Lémur Innovation
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
Lémur Innovation technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature7 records
Lémur Innovation partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor and core.
- CERP Colmar-MulhouseminorRegional CERP branch in Colmar-Mulhouse co-organized a pharmacy evening with Pharm-UPP 68-88 and Lémur Innovation in Rouffach (April 2026), featuring president Benoit Schott and director Charbonnier L. Event gathered UPP members from the territory for solution presentation and networking.
- CPTS Pays des Couleurs (Isère – 38)coreCPTS Pays des Couleurs partnered with Lémur Innovation to combat medication iatrogenicity in elderly patients. The initiative deploys new pharmaceutical missions across the territory using Lémur solutions, associating all equipped healthcare professionals. Led by Coralie Manfrin, the partnership aims to secure care pathways, optimize medication management and patient follow-up, and enhance the clinical role of pharmacists.
- CERP (Confraternelle d'Exploitation et de Répartition Pharmaceutique)coreCERP and Lémur Innovation announced a strategic partnership in January 2025 for national deployment of Lémur solutions. This collaboration leverages CERP's distribution network to reach pharmacies across France. The partnership is based on shared values of commitment to pharmaceutical care deployment in both city and hospital settings. A national launch offer was made available to new Lémur subscribers through CERP representatives.
- Positive PharmaminorPositive Pharma pharmacy network organizes evenings with Lémur Innovation to present solutions and latest evolutions to member pharmacists. Partnership involves events in cities including Lyon, with Carine Monaco as the key contact at Positive Pharma. Focuses on exchanging on current pharmacy challenges and new practices.
- Pharm-UPP (68-88, 39, Montpellier sections)minorPharm-UPP regional pharmacy groups organize salons and evenings where Lémur Innovation presents its solutions. Sections 68-88 (Alsace/Vosges), 39 (Jura), and Montpellier have partnered with Lémur. Events themed around beach/travel aesthetics attract 160+ participants. Organized by Benoit Schott (President) with CERP Colmar-Mulhouse participation.
- Centre de Réadaptation de MulhouseminorListed as a supporter and partner of Lémur Innovation on the company's official partners page. A rehabilitation center in Mulhouse, Alsace.
- CJ FormationminorTraining partner shown on the Lémur Innovation partners page. CJ Formation provides pharmaceutical training services and works alongside Lémur's software and formation offerings.
Scale indicators12 records
Recent moves6 records
Expansion highlights5 records
Lémur Innovation competitors and assessment
Company assessmentEmerging players
- Qare: Qare is a French telehealth and digital health platform offering remote consultations and chronic-condition follow-up. It intersects with Lémur on patient accompaniment and chronic-condition management use cases addressed by APP Longs, though Qare is physician-led rather than pharmacy-led.
- Maiia (by Cegedim): Maiia is Cegedim's French telehealth and appointment-management platform serving both physicians and pharmacists. It overlaps with Lémur at the intersection of pharmacy patient communication and digital care workflows, though it does not currently offer full medication reconciliation or pharmaceutical care mission software.
- Observia: Observia is a French digital health company focused on patient engagement, therapeutic adherence, and real-world evidence for chronic patients. It is comparable to Lémur's APP Longs and ETP modules in the patient accompaniment and observance-improvement space, though it operates across multiple therapeutic areas rather than French pharmacy workflows specifically.
Others
- Lifen: Lifen is a French health data exchange and document-sharing platform connecting healthcare professionals. It is an adjacent ecosystem player — not a direct competitor — but could be a partner or integration layer for Lémur's city-hospital data flows and care coordination workflows.
- Vidal: Vidal is the canonical French drug information database used by virtually every healthcare professional in France. It is an enabling ecosystem provider for medication-related software (Lémur's products depend on accurate drug data), and a potential integration or partnership target rather than a direct competitor.
Broad incumbents
- Doctolib: Doctolib is the dominant French digital health platform for appointment booking, telehealth, and patient communication, used by physicians and increasingly by pharmacies. While it does not currently specialize in medication reconciliation, its scale, brand, and expanding scope into pharmacy-adjacent services make it a broad incumbent that could extend into pharmaceutical care missions.
- Cegedim: Cegedim is a major French health IT group offering pharmacy software (including historical SPire pharmacy solutions), physician practice tools, and insurer/payer platforms. It overlaps with Lémur on pharmacy workflow software and medication management, but operates across the broader healthcare ecosystem rather than specializing in pharmaceutical care missions.
Direct peers
- Alliadis: Alliadis is a French pharmacy management software vendor providing dispensing and workflow tools to community pharmacies, with an installed base of independent and group pharmacies. It is a direct comparable on pharmacy software category and customer base, although its product depth in pharmaceutical care missions is narrower than Lémur's.
- Equasens (formerly Pharmagest Interactive): Equasens is the leading French pharmacy software vendor (LGPI, SPire, DLPS), serving community pharmacies across France with management, dispensing, and increasingly pharmaceutical care modules. It is the most directly comparable competitor to Lémur in target market, customer base, and software category, but at vastly larger scale and with an installed base of thousands of French pharmacies.
Regional players
- Apotica: Apotica is a French pharmacy services and software company focused on supporting pharmacies with new missions and digital tools, comparable to Lémur's pharmaceutical care mission focus. It is positioned as a regional/specialized player rather than a national incumbent, and competes for the same pharmacy customer segment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Lémur Innovation social profiles
Digital presenceLémur Innovation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lémur Innovation leadership team
Management profileNumber of profiles
Lémur Innovation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lémur Innovation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lémur Innovation
What does Lémur Innovation do?
Lémur Innovation develops and sells a SaaS suite of digital pharmaceutical care software for French community pharmacies, hospitals, clinics and rehabilitation centers. The offering centers on medication reviews (Bilan Partagé de Médication), patient accompaniment (Accompagnement Pharmaceutique des Patients), prevention assessments, hospital medication reconciliation (Conciliation des Traitements Médicamenteux), therapeutic patient education and self-administration tools — all powered by its proprietary LemurIA artificial intelligence for medication risk evaluation and city-hospital connectivity.
Is Lémur Innovation a public or private company?
Lémur Innovation is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Lémur Innovation founded?
Lémur Innovation was founded in 2020. It employs 1 to 10 people.
Where is Lémur Innovation based?
Lémur Innovation is headquartered in Pfulgriesheim, France, in the Europe region.
How does Lémur Innovation make money?
Four revenue lines are on record. Software Subscription (SaaS) is the primary driver. The others are communication Packs (One-time and Annual), add-on Licenses and Accessories and professional Services - Training.
Who are Lémur Innovation's main competitors?
Emerging players on record are Qare, Maiia (by Cegedim) and Observia. Others are Lifen and Vidal. Broad incumbents are Doctolib and Cegedim. Direct peers are Alliadis and Equasens (formerly Pharmagest Interactive). Apotica is listed as a regional player.
Does Lémur Innovation have an API?
No public API is recorded for Lémur Innovation.
What industry is Lémur Innovation in?
Lémur Innovation's product category is Pharmacy Practice Software. Its primary akta.pro industry code is HLACAKAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools, with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 513210 and its SIC code is 7372.